David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Humana
HUM
$46.5B
| $10.8M | 0.02% |
44,492
-4,354
| -9% | -$1.07M |
|
877
Adient
ADNT
$1.46B
| $10.8M | 0.02% |
128,679
+72,780
| +130% | +$5.16M |
|
|
KITE
878
CALL
DELISTED
Kite Pharma, Inc.
KITE
| $10.8M | 0.02% |
60,000
| – | – |
|
879
Restaurant Brands International
QSR
$28.4B
| $10.7M | 0.02% |
168,139
+46,731
| +38% | +$2.89M |
|
|
QUOT
880
DELISTED
Quotient Technology Inc
QUOT
| $10.7M | 0.02% |
685,828
-3,617
| -0.5% | -$49.9K |
|
881
PUT
Trip.com Group
TCOM
$28.9B
| $10.7M | 0.02% |
203,400
+3,400
| +2% | +$185K |
|
882
Central Garden & Pet Co Class A
CENTA
$2.38B
| $10.7M | 0.02% |
360,530
-20,763
| -5% | -$550K |
|
883
SITE Centers
SITC
$160M
| $10.7M | 0.02% |
908,095
-602,754
| -40% | -$7.55M |
|
|
COWN
884
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $10.7M | 0.02% |
601,997
+31,947
| +6% | +$523K |
|
885
PUT
Under Armour
UAA
$2.22B
| $10.7M | 0.02% |
650,000
+113,600
| +21% | +$2.09M |
|
886
PUT
Transocean
RIG
$6.46B
| $10.7M | 0.02% |
993,200
+678,700
| +216% | +$5.84M |
|
887
CALL
Universal Display
OLED
$3.94B
| $10.7M | 0.02% |
82,900
+2,100
| +3% | +$254K |
|
888
CALL
Abbott
ABT
$200B
| $10.7M | 0.02% |
200,000
-111,400
| -36% | -$5.59M |
|
889
Puma Biotechnology
PBYI
$481M
| $10.6M | 0.02% |
88,911
-111,257
| -56% | -$10.3M |
|
890
CALL
Nike
NKE
$58.9B
| $10.6M | 0.02% |
205,200
-10,800
| -5% | -$606K |
|
|
NXH
891
Neighborhood Intelligence Inc
NXH
$385M
| $10.6M | 0.02% |
475,982
-13,865
| -3% | -$209K |
|
892
PUT
Walmart Inc
WMT
$834B
| $10.6M | 0.02% |
407,400
-171,600
| -30% | -$4.5M |
|
893
Capri Holdings
CPRI
$1.52B
| $10.6M | 0.02% |
221,580
+122,174
| +123% | +$4.96M |
|
|
AY
894
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $10.6M | 0.02% |
536,269
-12,212
| -2% | -$254K |
|
895
PUT
Diageo
DEO
$52.7B
| $10.6M | 0.02% |
79,900
+10,000
| +14% | +$1.29M |
|
896
Oceaneering
OII
$5.11B
| $10.5M | 0.02% |
399,839
-93,078
| -19% | -$2.25M |
|
|
EGOV
897
DELISTED
NIC Inc
EGOV
| $10.5M | 0.02% |
610,566
-76,041
| -11% | -$1.29M |
|
|
AVP
898
DELISTED
Avon Products, Inc.
AVP
| $10.5M | 0.02% |
4,492,469
+614,800
| +16% | +$1.82M |
|
899
AutoZone
AZO
$49.4B
| $10.5M | 0.02% |
17,581
-34,510
| -66% | -$18.4M |
|
900
Photronics
PLAB
$1.74B
| $10.5M | 0.02% |
1,181,352
+122,598
| +12% | +$1.09M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.